Overview

S-1 in Combination With Abraxane in Treating Cholangiocarcinoma

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This phase II study was designed to evaluate the efficacy and safety of S-1 plus Abraxane as second-line treatment for cholangiocarcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Yuhong Li
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel